Fig. 3.
CART survival model.
This model identified the presence of peripheral blood IMCs as the strongest independent variable determining shorter survival, followed by the absolute lymphocyte count above 1.9 × 109/L and the hemoglobin level below 119 g/dL (11.9 g/dL) as main competitor variables. The process continued in the subset of patients with circulating IMCs above 0% and identified platelet counts of more than 93 × 109/L and 93 × 109/L or less as providing the best further discrimination of survival.
